Delivery Order SPE2DB22D1202-SPE2DB24FVLF1

Award Date 8/16/24
Potential Completion Date 8/19/24
Potential Value $72K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,257.48 firm-fixed-price delivery order is for the supply of RABAVERT RABIES VACC W-DILUENTS, a critical medical product. The contract has an ultimate completion date of April 4, 2025 and was awarded on April 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,431.10 firm fixed-price delivery order is for RABAVERT RABIES VACC W-DILUENTS, a critical medical commodity. The contract has an ultimate completion date of February 28, 2025 and was awarded on February 27, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,002.20 firm fixed-price delivery order is for the supply of RABAVERT rabies vaccine with diluents. The contract has an ultimate completion date of November 14, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,967.86 Firm Fixed Price Delivery Order contract is for the supply of RABAVERT rabies vaccine with diluents. The contract has a completion date of July 9, 2024 and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,895.45 firm fixed-price delivery order is for the supply of RABAVERT Rabies Vaccine with diluents, with a completion date of September 12, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,954.50 firm fixed-price delivery order is for the supply of RABAVERT Rabies Vaccine with diluents. The contract has an ultimate completion date of October 30, 2024. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,530.73 firm fixed-price delivery order is for the supply of RABAVERT RABIES VACCINE WITH DILUENTS. The contract has an ultimate completion date of December 9, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November...
This federal contract award, valued at $6,287.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RABAVERT RABIES VACC W-DILUENTS, a vaccine product, with an ultimate completion date of April 23, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,047.90 firm fixed-price delivery order is for RABAVERT RABIES VACC W-DILUENTS, with a period of performance through March 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,161.90 firm fixed-price delivery order is for the procurement of RABAVERT rabies vaccine with diluents, with a performance period through March 6, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVLF1
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor in the United States. The $72,010.25 firm-fixed-price delivery order is for the supply of RABAVERT RABIES VACC W-DILUENTS, a critical vaccine product. The contract has an ultimate completion date of August 19, 2024 and does not utilize any set-aside designations.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This award appears to be a task order issued under that broader IDC vehicle, enabling the government to efficiently procure essential pharmaceutical products from a trusted supplier to support the healthcare needs of military personnel and other federal beneficiaries.

Generated 11/15/24, 9:28 AM